 | • レポートコード：D0GIR-02332 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、医療バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。医療バイオマーカーの種類別市場規模（敗血症バイオマーカー、抗生物質耐性バイオマーカー、外傷性脳損傷（TBI）検査バイオマーカー、脳卒中検査バイオマーカー、抗生物質スチュワードシップバイオマーカー、その他）、用途別市場規模（診断、創薬、個別化医療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Abbott、QIAGEN、Merck、Siemens Healthcare、Bio-Rad Laboratories、Danaher Corporation、Roche、Agilent Technologies ・地域別グローバル市場分析 2015年-2020年 ・医療バイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・医療バイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・医療バイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・医療バイオマーカーの南米市場（ブラジル、アルゼンチン） ・医療バイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：敗血症バイオマーカー、抗生物質耐性バイオマーカー、外傷性脳損傷（TBI）検査バイオマーカー、脳卒中検査バイオマーカー、抗生物質スチュワードシップバイオマーカー、その他 ・用途別分析：診断、創薬、個別化医療、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Medical Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Medical Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Medical Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Medical Biomarkers market has been segmented into:
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
By Application, Medical Biomarkers has been segmented into:
Diagnostics
Drug Discovery
Personalized Medicine
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Medical Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Medical Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Medical Biomarkers market.
The report offers in-depth assessment of the growth and other aspects of the Medical Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Medical Biomarkers Market Share Analysis
Medical Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Medical Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Medical Biomarkers sales, revenue and market share for each player covered in this report.
The major players covered in Medical Biomarkers are:
Thermo Fisher Scientific
Abbott
QIAGEN
Merck
Siemens Healthcare
Bio-Rad Laboratories
Danaher Corporation
Roche
Agilent Technologies
Among other players domestic and global, Medical Biomarkers market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Medical Biomarkers Market Overview
1.1 Product Overview and Scope of Medical Biomarkers
1.2 Classification of Medical Biomarkers by Type
1.2.1 Global Medical Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Medical Biomarkers Revenue Market Share by Type in 2019
1.2.3 Sepsis Biomarkers
1.2.4 Antibiotic Resistance Biomarkers
1.2.5 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.6 Stroke Testing Biomarkers
1.2.7 Antibiotic Stewardship Biomarkers
1.2.8 Other
1.3 Global Medical Biomarkers Market by Application
1.3.1 Overview: Global Medical Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Global Medical Biomarkers Market by Regions
1.4.1 Global Medical Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Medical Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Medical Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Medical Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Medical Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Medical Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Medical Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott SWOT Analysis
2.2.4 Abbott Product and Services
2.2.5 Abbott Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 QIAGEN
2.3.1 QIAGEN Details
2.3.2 QIAGEN Major Business
2.3.3 QIAGEN SWOT Analysis
2.3.4 QIAGEN Product and Services
2.3.5 QIAGEN Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare SWOT Analysis
2.5.4 Siemens Healthcare Product and Services
2.5.5 Siemens Healthcare Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Product and Services
2.6.4 Bio-Rad Laboratories Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.7 Danaher Corporation
2.7.1 Danaher Corporation Details
2.7.2 Danaher Corporation Major Business
2.7.3 Danaher Corporation Product and Services
2.7.4 Danaher Corporation Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Product and Services
2.8.4 Roche Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Product and Services
2.9.4 Agilent Technologies Medical Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Medical Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Medical Biomarkers Players Market Share
3.2.2 Top 10 Medical Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Medical Biomarkers Revenue and Market Share by Regions
4.2 North America Medical Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Medical Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Medical Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Medical Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Medical Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Medical Biomarkers Revenue by Countries
5.1 North America Medical Biomarkers Revenue by Countries (2015-2020)
5.2 USA Medical Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Medical Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Medical Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Medical Biomarkers Revenue by Countries
6.1 Europe Medical Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Medical Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Medical Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Medical Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Medical Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Medical Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Medical Biomarkers Revenue by Countries
7.1 Asia-Pacific Medical Biomarkers Revenue by Countries (2015-2020)
7.2 China Medical Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Medical Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Medical Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Medical Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Medical Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Medical Biomarkers Revenue by Countries
8.1 South America Medical Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Medical Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Medical Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Medical Biomarkers by Countries
9.1 Middle East & Africa Medical Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Medical Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Medical Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Medical Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Medical Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Medical Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Medical Biomarkers Market Forecast by Type (2019-2024)
10.3 Sepsis Biomarkers Revenue Growth Rate (2015-2025)
10.4 Antibiotic Resistance Biomarkers Revenue Growth Rate (2015-2025)
10.5 Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Growth Rate (2015-2025)
10.6 Stroke Testing Biomarkers Revenue Growth Rate (2015-2025)
10.7 Antibiotic Stewardship Biomarkers Revenue Growth Rate (2015-2025)
10.8 Other Revenue Growth Rate (2015-2025)
11 Global Medical Biomarkers Market Segment by Application
11.1 Global Medical Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Medical Biomarkers Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2015-2020)
11.4 Drug Discovery Revenue Growth (2015-2020)
11.5 Personalized Medicine Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Medical Biomarkers Market Size Forecast (2021-2025)
12.1 Global Medical Biomarkers Market Size Forecast (2021-2025)
12.2 Global Medical Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Medical Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Medical Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Medical Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Medical Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Medical Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Medical Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Medical Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Medical Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Medical Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Medical Biomarkers Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 7. Thermo Fisher Scientific Medical Biomarkers Major Business
Table 8. Thermo Fisher Scientific Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 9. Thermo Fisher Scientific SWOT Analysis
Table 10. Thermo Fisher Scientific Medical Biomarkers Product and Solutions
Table 11. Thermo Fisher Scientific Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Abbott Corporate Information, Location and Competitors
Table 13. Abbott Medical Biomarkers Major Business
Table 14. Abbott Medical Biomarkers Total Revenue (USD Million) (2018-2019)
Table 15. Abbott SWOT Analysis
Table 16. Abbott Medical Biomarkers Product and Solutions
Table 17. Abbott Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. QIAGEN Corporate Information, Location and Competitors
Table 19. QIAGEN Medical Biomarkers Major Business
Table 20. QIAGEN Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 21. QIAGEN SWOT Analysis
Table 22. QIAGEN Medical Biomarkers Product and Solutions
Table 23. QIAGEN Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Merck Corporate Information, Location and Competitors
Table 25. Merck Medical Biomarkers Major Business
Table 26. Merck Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 27. Merck SWOT Analysis
Table 28. Merck Medical Biomarkers Product and Solutions
Table 29. Merck Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Siemens Healthcare Corporate Information, Location and Competitors
Table 31. Siemens Healthcare Medical Biomarkers Major Business
Table 32. Siemens Healthcare Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 33. Siemens Healthcare SWOT Analysis
Table 34. Siemens Healthcare Medical Biomarkers Product and Solutions
Table 35. Siemens Healthcare Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 37. Bio-Rad Laboratories Medical Biomarkers Major Business
Table 38. Bio-Rad Laboratories Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 39. Bio-Rad Laboratories SWOT Analysis
Table 40. Bio-Rad Laboratories Medical Biomarkers Product and Solutions
Table 41. Bio-Rad Laboratories Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Danaher Corporation Corporate Information, Location and Competitors
Table 43. Danaher Corporation Medical Biomarkers Major Business
Table 44. Danaher Corporation Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 45. Danaher Corporation SWOT Analysis
Table 46. Danaher Corporation Medical Biomarkers Product and Solutions
Table 47. Danaher Corporation Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Roche Corporate Information, Location and Competitors
Table 49. Roche Medical Biomarkers Major Business
Table 50. Roche Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 51. Roche SWOT Analysis
Table 52. Roche Medical Biomarkers Product and Solutions
Table 53. Roche Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Agilent Technologies Corporate Information, Location and Competitors
Table 55. Agilent Technologies Medical Biomarkers Major Business
Table 56. Agilent Technologies Medical Biomarkers Total Revenue (USD Million) (2017-2018)
Table 57. Agilent Technologies SWOT Analysis
Table 58. Agilent Technologies Medical Biomarkers Product and Solutions
Table 59. Agilent Technologies Medical Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Medical Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 61. Global Medical Biomarkers Revenue Share by Players (2015-2020)
Table 62. Global Medical Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Medical Biomarkers Revenue Market Share by Regions (2015-2020)
Table 64. North America Medical Biomarkers Revenue by Countries (2015-2020)
Table 65. North America Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Table 66. Europe Medical Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Medical Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Medical Biomarkers Revenue by Countries (2015-2020)
Table 69. South America Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Medical Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Table 72. Global Medical Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 73. Global Medical Biomarkers Revenue Share by Type (2015-2020)
Table 74. Global Medical Biomarkers Revenue Forecast by Type (2021-2025)
Table 75. Global Medical Biomarkers Revenue by Application (2015-2020)
Table 76. Global Medical Biomarkers Revenue Share by Application (2015-2020)
Table 77. Global Medical Biomarkers Revenue Forecast by Application (2021-2025)
Table 78. Global Medical Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Medical Biomarkers Picture
Figure 2. Global Medical Biomarkers Revenue Market Share by Type in 2019
Figure 3. Sepsis Biomarkers Picture
Figure 4. Antibiotic Resistance Biomarkers Picture
Figure 5. Traumatic Brain Injury (TBI) Testing Biomarkers Picture
Figure 6. Stroke Testing Biomarkers Picture
Figure 7. Antibiotic Stewardship Biomarkers Picture
Figure 8. Other Picture
Figure 9. Medical Biomarkers Revenue Market Share by Application in 2019
Figure 10. Diagnostics Picture
Figure 11. Drug Discovery Picture
Figure 12. Personalized Medicine Picture
Figure 13. Other Picture
Figure 14. Global Medical Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Medical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Medical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Medical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Medical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Medical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Medical Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Medical Biomarkers Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Medical Biomarkers Revenue Market Share in 2019
Figure 23. Global Top 10 Players Medical Biomarkers Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Medical Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Medical Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 27. Global Medical Biomarkers Revenue Market Share by Regions in 2018
Figure 28. North America Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. Europe Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 31. South America Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 33. North America Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 34. North America Medical Biomarkers Revenue Market Share by Countries in 2019
Figure 35. USA Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 36. Canada Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 38. Europe Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Medical Biomarkers Revenue Market Share by Countries in 2019
Figure 40. Germany Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. UK Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 42. France Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 43. Russia Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 44. Italy Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Medical Biomarkers Revenue Market Share by Countries in 2019
Figure 47. China Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. Japan Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 49. Korea Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 50. India Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 52. South America Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 53. South America Medical Biomarkers Revenue Market Share by Countries in 2019
Figure 54. Brazil Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Medical Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Medical Biomarkers Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 59. UAE Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Medical Biomarkers Revenue and Growth Rate (2015-2020)
Figure 62. Global Medical Biomarkers Revenue Share by Type (2015-2020)
Figure 63. Global Medical Biomarkers Revenue Share by Type in 2019
Figure 64. Global Medical Biomarkers Market Share Forecast by Type (2021-2025)
Figure 65. Global Sepsis Biomarkers Revenue Growth Rate (2015-2020)
Figure 66. Global Antibiotic Resistance Biomarkers Revenue Growth Rate (2015-2020)
Figure 67. Global Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Growth Rate (2015-2020)
Figure 68. Global Stroke Testing Biomarkers Revenue Growth Rate (2015-2020)
Figure 69. Global Antibiotic Stewardship Biomarkers Revenue Growth Rate (2015-2020)
Figure 70. Global Other Revenue Growth Rate (2015-2020)
Figure 71. Global Medical Biomarkers Revenue Share by Application (2015-2020)
Figure 72. Global Medical Biomarkers Revenue Share by Application in 2019
Figure 73. Global Medical Biomarkers Market Share Forecast by Application (2021-2025)
Figure 74. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 75. Global Drug Discovery Revenue Growth Rate (2015-2020)
Figure 76. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Medical Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Medical Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Medical Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Medical Biomarkers Revenue Market Forecast (2021-2025)
Figure 82. Europe Medical Biomarkers Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Medical Biomarkers Revenue Market Forecast (2021-2025)
Figure 84. South America Medical Biomarkers Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Medical Biomarkers Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
PARP阻害剤バイオマーカー検査製品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The PARP Inhibitor Biomarkers Testing Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…- PARP阻害剤バイオマーカーサービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The PARP Inhibitor Biomarkers Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 非侵襲的がんバイオマーカーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Noninvasive Cancer Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Noninvasive Can…
- 予測バイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Predictive Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Predictive Biomarkers m…
- EPOバイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global EPO Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The EPO Biomarkers market report p…